CKDXF Earnings
Ceryvyn Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -97.7%
1Y: -97.7%
3Y: -97.6%
5Y: -99.1%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-08-31
EPS
A$-0.00 (US$-0.00)
▼ Miss +0.0%
Revenue
—
Estimate vs Actual
Earnings Surprise History
0/16
EPS Beats
1/16
Revenue Beats
0%
EPS Beat Rate
6%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | annual | 2028-06-30 | A$-0.00 | A$-0.00 | — | A$2,945,645 | A$2,856,675 |
| 2026-07-31 | annual | 2027-06-30 | A$-0.00 | A$-0.00 | — | A$790,295 | A$766,425 |
| 2026-06-10 | annual | 2028-06-30 | A$-0.00 | A$-0.00 | — | A$63,927,000 | A$2,945,645 |
| 2026-06-10 | annual | 2027-06-30 | A$-0.00 | A$-0.00 | — | A$200,000 | A$790,295 |
| 2026-02-12 | annual | 2029-06-30 | A$— | A$0.00 | — | A$— | A$154,802,000 |
| 2026-02-12 | annual | 2025-06-30 | A$— | A$-0.17 | ▼ 0.17 | A$— | A$200,000 |
| 2026-02-12 | annual | 2026-06-30 | A$— | A$-0.00 | — | A$— | A$200,000 |
| 2026-02-12 | annual | 2024-06-30 | A$— | A$-0.21 | ▼ 0.21 | A$— | A$550,000 |
| 2026-02-12 | quarter | 2025-06-30 | A$— | A$-0.01 | ▼ 0.01 | A$— | A$100,000 |
| 2026-02-12 | annual | 2023-06-30 | A$— | A$-0.22 | ▼ 0.22 | A$— | A$1,548,200 |
| 2026-02-12 | annual | 2028-06-30 | A$— | A$-0.00 | — | A$— | A$63,927,000 |
| 2026-02-12 | annual | 2027-06-30 | A$— | A$-0.00 | — | A$— | A$200,000 |
| 2026-02-12 | quarter | 2024-06-30 | A$— | A$-0.16 | ▼ 0.16 | A$— | A$100,000 |
Earnings Call Transcripts
No transcripts available.